Craft
  • Home
  •  / Harvard Bioscience
Harvard Bioscience

Harvard Bioscience

Revenue

$118.9 M

FY, 2021

Market Capitalization

$106.1 M

2022-09-22

Harvard Bioscience Summary

Company summary

Overview
Harvard Bioscience is a global developer, manufacturer, and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. The Company sells its products to thousands of researchers through its full-line catalog (and various other specialty catalogs), its websites, and through distributors, including GE Healthcare, Thermo Fisher Scientific Inc., and VWR.
Type
Public
Founded
1901
HQ
Holliston, MA, US | view all locations
Website
http://www.harvardbioscience.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • James Green

    James Green, Chairman, President and Chief Executive Officer

    • Michael Rossi

      Michael Rossi, Chief Financial Officer

      • Katherine A. Eade, Director

        • John Kennedy, Director

          LocationsView all

          4 locations detected

          • Holliston, MA HQ

            United States

            84 October Hill Rd

          • Montréal, QC

            Canada

            6010 Rue Vanden Abeele, Saint-Laurent

          • Shanghai Shi

            China

            121 Jiangsu Rd, Changning Qu

          • Les Ulis, IDF

            France

            6 Avenue des Andes

          Harvard Bioscience Financials

          Summary financials

          Revenue (Q2, 2022)
          $29.2M
          Gross profit (Q2, 2022)
          $16.6M
          Net income (Q2, 2022)
          $2.4M
          Cash (Q2, 2022)
          $4.3M
          EBIT (Q2, 2022)
          $4.0M
          Enterprise value
          $150.6M

          Footer menu